Cadrenal Therapeutics, Inc. Human Resources Contracts & Agreements
14 Contracts & Agreements
- Bonus & Incentive Agreements (6 contracts)
- Consulting Agreements (2)
- Employment Agreements (6)
- Amendment No. 1 to Employment Agreement by and between Cadrenal Therapeutics, Inc. and Matthew Szot, dated May 25, 2023 (Filed With SEC on May 26, 2023)
- Employment Agreement, effective as of January 24, 2023, by and between Cadrenal Therapeutics, Inc. and Douglas Losordo (Filed With SEC on January 25, 2023)
- Employment Agreement, dated January 24, 2023, by and between Cadrenal Therapeutics, Inc. and Matthew Szot (Filed With SEC on January 25, 2023)
- Form of Restricted Stock Unit Grant Notice and Restricted Stock Unit Award Agreement under the 2022 Successor Equity Incentive Plan (Filed With SEC on October 17, 2022)
- Form of Stock Option Grant Notice, Stock Option Agreement and Notice of Exercise under the 2022 Successor Equity Incentive Plan (Filed With SEC on October 17, 2022)
- Cadrenal Therapeutics, Inc. 2022 Successor Equity Incentive Plan (Filed With SEC on October 17, 2022)
- Form of Stock Option Grant Notice, Stock Option Agreement and Notice of Exercise under the 2022 Amended and Restated Equity Incentive Plan (Filed With SEC on October 17, 2022)
- Cadrenal Therapeutics, Inc. 2022 Amended and Restated Equity Incentive Plan (Filed With SEC on October 17, 2022)
- Form of Employment Agreement to be entered into with Douglas Losordo (Filed With SEC on September 22, 2022)
- Form of Employment Agreement to be entered into with Matthew Szot (Filed With SEC on September 22, 2022)
- Consulting Agreement, dated May 17, 2022, with Matthew Szot (Filed With SEC on September 22, 2022)
- Employment Agreement, dated March1, 2022 with Quang Pham (Filed With SEC on September 22, 2022)
- Consulting Agreement, dated January 25, 2022, with Phamace LLC (Quang Pham) from company formation until initiation of payroll (Filed With SEC on September 22, 2022)
- Cadrenal Therapeutics, Inc. 2022 Equity Incentive Plan and form of Incentive Stock Option Agreement, Non-Qualified Stock Option Agreement for Officers and Other Employees,... (Filed With SEC on September 22, 2022)